DEUTETRABENAZINE

DEUTETRABENAZINE was reported 7695 times

DEUTETRABENAZINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TONGUE THRUST 6 0.0667
1 CHRONIC CHEEK BITING 2 0.0465
2 COMPULSIVE CHEEK BITING 2 0.0392
3 COMPULSIVE LIP BITING 4 0.0385
4 ADRENAL GLAND OPERATION 1 0.0370
5 TONGUE MOVEMENT DISTURBANCE 29 0.0339
6 BEHAVIOURAL THERAPY 1 0.0333
7 BIOPSY TONGUE 1 0.0333
8 DRUG TITRATION ERROR 61 0.0236
9 LIVING IN RESIDENTIAL INSTITUTION 43 0.0229
10 ANTIDEPRESSANT THERAPY 1 0.0227
11 DYSTONIC TREMOR 2 0.0227
12 DRUG TITRATION 3 0.0192
13 CHOREA 30 0.0174
14 NASAL FLARING 2 0.0148
15 DYSKINESIA 524 0.0129
16 PARKINSONISM 124 0.0127
17 DROOLING 85 0.0123
18 DECREASED GAIT VELOCITY 2 0.0119
19 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 5 0.0117
20 SOCIOECONOMIC PRECARITY 2 0.0116
21 SPEECH SOUND DISORDER 2 0.0116
22 DENTURE WEARER 3 0.0116
23 TONGUE BITING 23 0.0111
24 PARKINSONIAN REST TREMOR 2 0.0106
25 SOLILOQUY 9 0.0104
26 GRUNTING 6 0.0100
27 AXONAL AND DEMYELINATING POLYNEUROPATHY 1 0.0098
28 TARDIVE DYSKINESIA 274 0.0097
29 JAW CLICKING 2 0.0094
30 BRUXISM 49 0.0091
31 GRIMACING 7 0.0090
32 TIC 48 0.0088
33 NASAL INFLAMMATION 9 0.0085
34 INJECTION SITE NERVE DAMAGE 2 0.0084
35 FACIAL SPASM 9 0.0080
36 POSITIVE AIRWAY PRESSURE THERAPY 2 0.0068
37 EXCESSIVE EYE BLINKING 10 0.0068
38 HAEMORRHOID OPERATION 3 0.0067
39 DRUG DOSE TITRATION NOT PERFORMED 12 0.0065
40 TONGUE SPASM 2 0.0064
41 ATTENTION-SEEKING BEHAVIOUR 1 0.0064
42 PATIENT DISSATISFACTION WITH TREATMENT 12 0.0062
43 AORTIC VALVE THICKENING 1 0.0062
44 SELF-INJURIOUS IDEATION 25 0.0060
45 ACUTE CARDIAC EVENT 1 0.0058
46 AKATHISIA 75 0.0055
47 OROMANDIBULAR DYSTONIA 4 0.0055
48 PATIENT ELOPEMENT 2 0.0055
49 ESSENTIAL TREMOR 6 0.0054
50 ABDOMINAL HERNIA REPAIR 1 0.0054
51 TRISMUS 27 0.0052
52 PROTRUSION TONGUE 3 0.0051
53 FAT TISSUE DECREASED 2 0.0051
54 PERSISTENT DEPRESSIVE DISORDER 2 0.0050
55 SITTING DISABILITY 3 0.0049
56 PARKINSONIAN GAIT 3 0.0048
57 CRANIOFACIAL FRACTURE 4 0.0047
58 HEARING AID USER 2 0.0047
59 SELF-DESTRUCTIVE BEHAVIOUR 4 0.0046
60 DOPAMINE DYSREGULATION SYNDROME 2 0.0045
61 THERAPY CHANGE 44 0.0045
62 DECREASED INTEREST 26 0.0044
63 BIPOLAR DISORDER 47 0.0043
64 SHOULDER FRACTURE 7 0.0043
65 NEGATIVE THOUGHTS 12 0.0041
66 AFFECTIVE DISORDER 32 0.0041
67 SUICIDAL IDEATION 372 0.0041
68 INSURANCE ISSUE 61 0.0040
69 BENIGN LUNG NEOPLASM 1 0.0040
70 WHEELCHAIR USER 17 0.0038
71 EYELID FUNCTION DISORDER 3 0.0038
72 RESTLESSNESS 133 0.0036
73 EMERGENCY CARE 11 0.0036
74 SUICIDAL BEHAVIOUR 15 0.0036
75 ANGIOGRAM 1 0.0036
76 MENTAL DISABILITY 2 0.0035
77 VASCULAR DEMENTIA 3 0.0034
78 DEPRESSIVE SYMPTOM 12 0.0034
79 NEAR DEATH EXPERIENCE 11 0.0033
80 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 157 0.0033
81 MASTICATION DISORDER 10 0.0033
82 ANAL SQUAMOUS CELL CARCINOMA 1 0.0032
83 INABILITY TO AFFORD MEDICATION 32 0.0032
84 ELECTROCARDIOGRAM T WAVE ABNORMAL 5 0.0032
85 DRUG EFFECT LESS THAN EXPECTED 47 0.0032
86 SEDATION COMPLICATION 8 0.0031
87 EXTREMITY CONTRACTURE 2 0.0031
88 INITIAL INSOMNIA 32 0.0031
89 PRODUCT SUPPLY ISSUE 22 0.0031
90 POSTURE ABNORMAL 10 0.0031
91 INTERCEPTED PRODUCT PRESCRIBING ERROR 4 0.0030
92 REDUCED FACIAL EXPRESSION 3 0.0030
93 CARDIAC FLUTTER 19 0.0029
94 PAINFUL ERECTION 2 0.0029
95 STARING 7 0.0029
96 WRONG DOSE 7 0.0029
97 NUTRITIONAL CONDITION ABNORMAL 2 0.0029
98 TERMINAL INSOMNIA 5 0.0028
99 TRYPTASE INCREASED 2 0.0028
100 BIPOLAR II DISORDER 1 0.0028
101 NASAL INJURY 2 0.0028
102 HYPERPHAGIA 11 0.0028
103 ANKLE ARTHROPLASTY 1 0.0028
104 VITAMIN B COMPLEX DEFICIENCY 2 0.0027
105 MOUTH INJURY 4 0.0026
106 NASAL DISORDER 7 0.0026
107 ARTERIAL RUPTURE 2 0.0026
108 VIOLENCE-RELATED SYMPTOM 4 0.0026
109 GASTROSTOMY 4 0.0026
110 CRITICAL ILLNESS 2 0.0026
111 MUSCLE TWITCHING 59 0.0026
112 INTRUSIVE THOUGHTS 3 0.0025
113 BRADYKINESIA 15 0.0025
114 SYMPTOM RECURRENCE 15 0.0025
115 SALIVARY HYPERSECRETION 25 0.0025
116 HOMICIDAL IDEATION 10 0.0025
117 DEPRESSION 550 0.0024
118 MOVEMENT DISORDER 77 0.0024
119 SPEECH DISORDER 125 0.0024
120 PRODUCT USED FOR UNKNOWN INDICATION 3 0.0024
121 FRACTURED COCCYX 3 0.0024
122 TREMOR 390 0.0023
123 PRODUCT USE ISSUE 435 0.0023
124 GASTRIC BYPASS 5 0.0023
125 FOOD REFUSAL 2 0.0023
126 OBSESSIVE THOUGHTS 4 0.0022
127 HEAD TITUBATION 3 0.0022
128 SEDATION 57 0.0022
129 ORAL ADMINISTRATION COMPLICATION 2 0.0022
130 HALLUCINATION, AUDITORY 34 0.0021
131 SCHIZOPHRENIA 26 0.0021
132 BIOPSY BONE MARROW 1 0.0021
133 IMPATIENCE 4 0.0021
134 HYPERSOMNIA 61 0.0021
135 WALKING AID USER 14 0.0021
136 NARCOLEPSY 4 0.0021
137 LIP DISORDER 4 0.0021
138 TOOTH INJURY 9 0.0021
139 SLOW SPEECH 5 0.0021
140 GASTRECTOMY 2 0.0020
141 LOGORRHOEA 7 0.0020
142 PSYCHOTIC BEHAVIOUR 2 0.0020
143 SOMNOLENCE 396 0.0020
144 EYE COLOUR CHANGE 2 0.0020
145 IMPAIRED SELF-CARE 4 0.0019
146 HOSPICE CARE 19 0.0019
147 AGGRESSION 96 0.0019
148 TRANSCRIPTION MEDICATION ERROR 3 0.0019
149 COGWHEEL RIGIDITY 2 0.0019
150 MOOD ALTERED 52 0.0019
151 THYROID HORMONES INCREASED 2 0.0019
152 SCREAMING 12 0.0019
153 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
154 EXOPHTHALMOS 4 0.0019
155 BINGE EATING 2 0.0019
156 AUTOSCOPY 1 0.0019
157 PRODUCT PRESCRIBING ERROR 44 0.0018
158 OROPHARYNGEAL BLISTERING 3 0.0018
159 CLAUSTROPHOBIA 2 0.0018
160 COMMUNICATION DISORDER 7 0.0018
161 DYSPHEMIA 8 0.0018
162 MANIA 30 0.0018
163 BIPOLAR I DISORDER 4 0.0018
164 DYSGRAPHIA 12 0.0018
165 RESTLESS LEGS SYNDROME 33 0.0018
166 PRODUCT DOSE OMISSION IN ERROR 51 0.0018
167 MAJOR DEPRESSION 13 0.0018
168 DRY MOUTH 143 0.0018
169 CRYING 64 0.0018
170 LAZINESS 3 0.0018
171 DEPRESSION SUICIDAL 6 0.0017
172 THERAPEUTIC PRODUCT EFFECT INCREASED 2 0.0017
173 MORBID THOUGHTS 2 0.0017
174 GAIT INABILITY 57 0.0017
175 SCHIZOAFFECTIVE DISORDER 3 0.0017
176 BALANCE DISORDER 142 0.0016
177 POST-TRAUMATIC STRESS DISORDER 11 0.0016
178 GASTROINTESTINAL TUBE INSERTION 4 0.0016
179 NASAL DRYNESS 10 0.0016
180 IMPAIRED DRIVING ABILITY 18 0.0016
181 HERNIA REPAIR 4 0.0015
182 CHOKING 30 0.0015
183 LISTLESS 5 0.0015
184 ABNORMAL SLEEP-RELATED EVENT 2 0.0015
185 PRODUCT PRESCRIBING ISSUE 33 0.0015
186 FRUSTRATION TOLERANCE DECREASED 12 0.0015
187 AGITATION 109 0.0015
188 PRODUCT USE IN UNAPPROVED INDICATION 367 0.0015
189 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 105 0.0015
190 DEMENTIA 41 0.0015
191 AGORAPHOBIA 2 0.0015
192 ASPIRATION 16 0.0015
193 EYE MOVEMENT DISORDER 10 0.0015
194 IMPULSE-CONTROL DISORDER 3 0.0015
195 AKINESIA 3 0.0014
196 TACHYPHRENIA 5 0.0014
197 SUDDEN ONSET OF SLEEP 2 0.0014
198 JOINT INSTABILITY 2 0.0014
199 SLEEP DEFICIT 3 0.0014
200 ANGER 48 0.0014
201 DEPRESSED MOOD 75 0.0014
202 HYPERKINESIA 3 0.0014
203 TORTICOLLIS 3 0.0014
204 BITE 1 0.0014
205 SLUGGISHNESS 14 0.0014
206 OBSESSIVE-COMPULSIVE DISORDER 11 0.0014
207 AORTIC VALVE SCLEROSIS 1 0.0014
208 THERAPY CESSATION 70 0.0014
209 DYSARTHRIA 51 0.0014
210 APRAXIA 2 0.0013
211 LOSS OF EMPLOYMENT 4 0.0013
212 CRANIOCEREBRAL INJURY 4 0.0013
213 INSOMNIA 348 0.0013
214 APATHY 19 0.0013
215 PRODUCT RESIDUE PRESENT 7 0.0013
216 FLAT AFFECT 3 0.0013
217 JAW DISORDER 7 0.0013
218 MOTOR DYSFUNCTION 13 0.0013
219 POLYDIPSIA 5 0.0013
220 ATAXIA 15 0.0013
221 FEELING JITTERY 24 0.0013
222 HEART RATE ABNORMAL 7 0.0013
223 GRIP STRENGTH DECREASED 11 0.0012
224 INTRACRANIAL ANEURYSM 5 0.0012
225 THINKING ABNORMAL 23 0.0012
226 FEEDING DISORDER 25 0.0012
227 PSYCHIATRIC SYMPTOM 9 0.0012
228 MENTAL DISORDER 53 0.0012
229 ILLUSION 2 0.0012
230 SOCIAL PROBLEM 5 0.0012
231 RHINORRHOEA 77 0.0012
232 CONTRAINDICATED PRODUCT PRESCRIBED 2 0.0012
233 ATTENTION DEFICIT HYPERACTIVITY DISORDER 5 0.0012
234 PSYCHOTIC DISORDER 35 0.0012
235 GLUCOSE TOLERANCE IMPAIRED 7 0.0012
236 SEIZURE LIKE PHENOMENA 2 0.0012
237 FOOD AVERSION 2 0.0012
238 SLEEP TALKING 2 0.0012
239 TONGUE DISCOMFORT 5 0.0012
240 RESPIRATION ABNORMAL 8 0.0012
241 DISTURBANCE IN ATTENTION 62 0.0011
242 PRODUCT DISPENSING ERROR 25 0.0011
243 PSYCHOMOTOR HYPERACTIVITY 19 0.0011
244 CATATONIA 6 0.0011
245 HALLUCINATION 86 0.0011
246 MUSCLE CONTRACTIONS INVOLUNTARY 4 0.0011
247 DYSPHAGIA 107 0.0011
248 EATING DISORDER 24 0.0011
249 VOCAL CORD PARALYSIS 2 0.0011
250 BEHAVIOUR DISORDER 6 0.0011
251 SKIN WRINKLING 3 0.0011
252 DIABETES MELLITUS 84 0.0011
253 LIP BLISTER 3 0.0011
254 CLUMSINESS 3 0.0011
255 NEUROLEPTIC MALIGNANT SYNDROME 13 0.0011
256 DISORGANISED SPEECH 2 0.0011
257 FALL 360 0.0011
258 HYPERPROLACTINAEMIA 7 0.0011
259 MENTAL IMPAIRMENT 26 0.0011
260 ELECTRIC SHOCK SENSATION 3 0.0011
261 BLADDER SPASM 2 0.0011
262 CONFUSIONAL STATE 170 0.0011
263 MUSCLE TIGHTNESS 17 0.0010
264 PANCREATIC CYST 2 0.0010
265 VOMITING PROJECTILE 3 0.0010
266 REHABILITATION THERAPY 4 0.0010
267 THERAPEUTIC PRODUCT EFFECT VARIABLE 4 0.0010
268 CONVERSION DISORDER 2 0.0010
269 ANIMAL SCRATCH 1 0.0010
270 PULMONARY PAIN 3 0.0010
271 BRAIN FOG 16 0.0010
272 STRABISMUS 3 0.0010
273 MIDDLE INSOMNIA 19 0.0010
274 HEAD INJURY 32 0.0010
275 THERAPEUTIC PRODUCT EFFECT DECREASED 45 0.0010
276 ANTISOCIAL BEHAVIOUR 1 0.0010
277 ANAL INCONTINENCE 9 0.0010
278 APHASIA 30 0.0010
279 ENURESIS 4 0.0010
280 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6 0.0010
281 MUSCLE CONTRACTURE 2 0.0010
282 ADVERSE EVENT 90 0.0010
283 HYPERPARATHYROIDISM 2 0.0010
284 HOSPITALISATION 149 0.0010
285 DELUSION 15 0.0010
286 ADVERSE DRUG REACTION 86 0.0010
287 WALKING DISABILITY 2 0.0010
288 INCONTINENCE 10 0.0009
289 STUPOR 3 0.0009
290 OCULOGYRIC CRISIS 2 0.0009
291 SWOLLEN TONGUE 29 0.0009
292 DIZZINESS POSTURAL 9 0.0009
293 PARANOIA 16 0.0009
294 CONTRAINDICATED PRODUCT ADMINISTERED 28 0.0009
295 SPUTUM INCREASED 2 0.0009
296 THERAPY INTERRUPTED 66 0.0009
297 BEDRIDDEN 12 0.0009
298 PEPTIC ULCER 3 0.0009
299 FEAR OF DEATH 2 0.0009
300 ABNORMAL BEHAVIOUR 35 0.0009
301 IMPAIRED GASTRIC EMPTYING 12 0.0009
302 PANIC ATTACK 32 0.0009
303 BRAIN OPERATION 2 0.0009
304 READING DISORDER 2 0.0009
305 EYELID DISORDER 2 0.0009
306 FEELING OF DESPAIR 4 0.0009
307 PATELLA FRACTURE 2 0.0009
308 MEMORY IMPAIRMENT 117 0.0009
309 BLOOD SODIUM DECREASED 16 0.0008
310 BLOOD PROLACTIN INCREASED 4 0.0008
311 FACIAL PARESIS 3 0.0008
312 HAND FRACTURE 6 0.0008
313 PULMONARY INFARCTION 2 0.0008
314 PANCREATITIS CHRONIC 2 0.0008
315 THERAPEUTIC RESPONSE SHORTENED 28 0.0008
316 URINARY INCONTINENCE 25 0.0008
317 SINUS OPERATION 2 0.0008
318 SLEEP DISORDER 59 0.0008
319 BACK INJURY 9 0.0008
320 DYSTONIA 16 0.0008
321 ORAL DISORDER 6 0.0008
322 MOUTH HAEMORRHAGE 6 0.0008
323 HAEMATOLOGICAL INFECTION 2 0.0008
324 HYPOMANIA 3 0.0008
325 MOOD SWINGS 26 0.0008
326 GAIT DISTURBANCE 156 0.0008
327 ANXIETY 231 0.0008
328 FEELING ABNORMAL 194 0.0008
329 FEELING DRUNK 6 0.0008
330 ORAL PAIN 18 0.0008
331 LETHARGY 46 0.0008
332 DRUG INEFFECTIVE 1053 0.0008
333 IRRITABILITY 48 0.0008
334 IMPAIRED WORK ABILITY 17 0.0008
335 PARANASAL SINUS DISCOMFORT 3 0.0008
336 HEAD DISCOMFORT 14 0.0008
337 DRUG TOLERANCE 4 0.0008
338 HUNGER 11 0.0008
339 BLOOD CHLORIDE DECREASED 2 0.0008
340 CONCUSSION 6 0.0008
341 PANIC DISORDER 3 0.0008
342 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 139 0.0008
343 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
344 PERSONALITY DISORDER 2 0.0008
345 DISABILITY 15 0.0008
346 HEART RATE IRREGULAR 17 0.0008
347 OBSTRUCTION 3 0.0008
348 ANIMAL BITE 2 0.0007
349 ELECTROCARDIOGRAM QT PROLONGED 27 0.0007
350 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
351 COGNITIVE DISORDER 35 0.0007
352 ALCOHOL POISONING 2 0.0007
353 SPINAL FUSION SURGERY 3 0.0007
354 CHONDROPATHY 2 0.0007
355 RHINALGIA 2 0.0007
356 SPINAL STENOSIS 3 0.0007
357 TOOTH FRACTURE 8 0.0007
358 DRUG SCREEN FALSE POSITIVE 2 0.0007
359 PHARYNGEAL SWELLING 7 0.0007
360 NECK MASS 2 0.0007
361 FACIAL PARALYSIS 6 0.0007
362 PRODUCT DISPENSING ISSUE 3 0.0007
363 PRODUCT USE COMPLAINT 11 0.0007
364 TEARFULNESS 3 0.0007
365 LIP PAIN 2 0.0007
366 HYPERTONIC BLADDER 2 0.0007
367 CHAPPED LIPS 3 0.0007
368 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
369 TONGUE DISORDER 5 0.0007
370 HYPERVENTILATION 4 0.0007
371 INCREASED APPETITE 13 0.0007
372 ENERGY INCREASED 4 0.0007
373 LOWER LIMB FRACTURE 13 0.0007
374 MUSCLE RIGIDITY 8 0.0007
375 INTENTIONAL DOSE OMISSION 19 0.0007
376 NIGHTMARE 23 0.0007
377 OROPHARYNGEAL DISCOMFORT 6 0.0007
378 SUSPECTED OFF LABEL USE 3 0.0007
379 HALLUCINATION, VISUAL 14 0.0007
380 ADHESION 1 0.0007
381 JOINT DISLOCATION 7 0.0007
382 MUSCULOSKELETAL STIFFNESS 58 0.0007
383 DEATH 559 0.0006
384 PRODUCT DISTRIBUTION ISSUE 6 0.0006
385 COORDINATION ABNORMAL 9 0.0006
386 FAMILY STRESS 2 0.0006
387 PAIN IN JAW 18 0.0006
388 FOREIGN BODY IN THROAT 2 0.0006
389 NASAL DISCOMFORT 5 0.0006
390 POLYMYALGIA RHEUMATICA 2 0.0006
391 AORTIC VALVE DISEASE 1 0.0006
392 HYPOKINESIA 9 0.0006
393 ANTICONVULSANT DRUG LEVEL INCREASED 1 0.0006
394 ACUTE LEUKAEMIA 1 0.0006
395 INCOHERENT 4 0.0006
396 THIRST 11 0.0006
397 PRODUCT DOSE OMISSION ISSUE 181 0.0006
398 KNEE OPERATION 6 0.0006
399 SOMNAMBULISM 4 0.0006
400 APPETITE DISORDER 4 0.0006
401 SKIN INJURY 2 0.0006
402 LYME DISEASE 2 0.0006
403 AMNESIA 39 0.0006
404 BRAIN INJURY 6 0.0006
405 WITHDRAWAL SYNDROME 25 0.0006
406 PRODUCT ADMINISTRATION ERROR 12 0.0006
407 ILLNESS 61 0.0006
408 ULCER HAEMORRHAGE 4 0.0006
409 EUPHORIC MOOD 6 0.0006
410 CARDIAC OPERATION 5 0.0006
411 ANKLE FRACTURE 9 0.0006
412 ABNORMAL DREAMS 16 0.0006
413 PALPITATIONS 67 0.0006
414 FOOD CRAVING 3 0.0006
415 URINARY RETENTION 19 0.0006
416 SPINAL OPERATION 7 0.0006
417 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 115 0.0006
418 GLOSSITIS 2 0.0006
419 POOR QUALITY SLEEP 12 0.0006
420 IMPAIRED QUALITY OF LIFE 8 0.0006
421 SINUS DISORDER 11 0.0006
422 THROAT TIGHTNESS 15 0.0006
423 CHEILITIS 3 0.0006
424 PHARYNGITIS STREPTOCOCCAL 6 0.0006
425 DYSSTASIA 16 0.0005
426 AUTISM SPECTRUM DISORDER 3 0.0005
427 SEBORRHOEA 2 0.0005
428 DEAFNESS UNILATERAL 3 0.0005
429 UNRESPONSIVE TO STIMULI 14 0.0005
430 CEREBRAL DISORDER 4 0.0005
431 PERSONALITY CHANGE 5 0.0005
432 NEURODERMATITIS 2 0.0005
433 NERVOUSNESS 28 0.0005
434 THROAT CLEARING 2 0.0005
435 IMPULSIVE BEHAVIOUR 2 0.0005
436 DIZZINESS 265 0.0005
437 CHEMOTHERAPY 2 0.0005
438 HIP FRACTURE 17 0.0005
439 SUICIDE ATTEMPT 32 0.0005
440 FACE INJURY 2 0.0005
441 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
442 SLEEP APNOEA SYNDROME 10 0.0005
443 THYROID MASS 2 0.0005
444 MOUTH SWELLING 3 0.0005
445 ARTERIAL THROMBOSIS 1 0.0005
446 MUSCLE RUPTURE 2 0.0005
447 THERAPEUTIC RESPONSE UNEXPECTED 23 0.0005
448 URINE ODOUR ABNORMAL 3 0.0005
449 SKIN ODOUR ABNORMAL 2 0.0005
450 LIGAMENT SPRAIN 5 0.0005
451 SEIZURE 58 0.0005
452 STENT PLACEMENT 4 0.0005
453 INTENTIONAL SELF-INJURY 10 0.0005
454 VITAMIN B12 DEFICIENCY 2 0.0005
455 NASAL CONGESTION 29 0.0005
456 TENSION 3 0.0005
457 GLOSSODYNIA 11 0.0005
458 BLINDNESS 20 0.0005
459 THERAPY NON-RESPONDER 22 0.0005
460 HYPOACUSIS 21 0.0005
461 RIB FRACTURE 10 0.0005
462 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
463 BLEPHAROSPASM 3 0.0005
464 LOSS OF CONSCIOUSNESS 61 0.0005
465 HALLUCINATIONS, MIXED 2 0.0005
466 BUNDLE BRANCH BLOCK LEFT 2 0.0005
467 FATIGUE 366 0.0005
468 UTERINE HAEMORRHAGE 2 0.0005
469 MENTAL STATUS CHANGES 13 0.0005
470 DRUG INTOLERANCE 45 0.0005
471 TENSION HEADACHE 2 0.0005
472 HORDEOLUM 2 0.0005
473 PRODUCT PREPARATION ISSUE 3 0.0005
474 ONYCHOMYCOSIS 2 0.0005
475 GASTROINTESTINAL PAIN 5 0.0005
476 BLOOD PRESSURE ABNORMAL 9 0.0005
477 LIMB DISCOMFORT 14 0.0005
478 RHINITIS ALLERGIC 2 0.0004
479 TRANSIENT ISCHAEMIC ATTACK 15 0.0004
480 SINUS CONGESTION 6 0.0004
481 WRONG PRODUCT ADMINISTERED 3 0.0004
482 LIP DRY 4 0.0004
483 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
484 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
485 DISEASE COMPLICATION 2 0.0004
486 EAR DISORDER 2 0.0004
487 EYE OPERATION 2 0.0004
488 INTERCEPTED MEDICATION ERROR 2 0.0004
489 ARTHRITIS INFECTIVE 2 0.0004
490 EXTRASYSTOLES 3 0.0004
491 NEPHROPATHY 4 0.0004
492 URINARY TRACT INFECTION 73 0.0004
493 SUSPECTED SUICIDE 2 0.0004
494 HEART RATE INCREASED 42 0.0004
495 SKIN ABRASION 2 0.0004
496 EMOTIONAL DISORDER 13 0.0004
497 PARALYSIS 6 0.0004
498 INCORRECT DOSAGE ADMINISTERED 2 0.0004
499 INCORRECT DOSE ADMINISTERED 93 0.0004
500 MUSCULOSKELETAL DISCOMFORT 7 0.0004
501 BREATH SOUNDS ABNORMAL 2 0.0004
502 MUSCULAR WEAKNESS 46 0.0004
503 DIABETIC NEUROPATHY 2 0.0004
504 HYPERHIDROSIS 52 0.0004
505 HYPERNATRAEMIA 2 0.0004
506 HEPATIC ENZYME ABNORMAL 2 0.0004
507 HYPOAESTHESIA ORAL 6 0.0004
508 DRUG INTERACTION 63 0.0004
509 PRODUCT SOLUBILITY ABNORMAL 2 0.0004
510 ABDOMINAL INFECTION 1 0.0004
511 FOOD ALLERGY 3 0.0004
512 PLATELET COUNT INCREASED 5 0.0004
513 MALABSORPTION 2 0.0004
514 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
515 CONDITION AGGRAVATED 116 0.0004
516 FURUNCLE 3 0.0004
517 DISORIENTATION 15 0.0004
518 VERTIGO 23 0.0004
519 RETCHING 8 0.0004
520 JOINT INJURY 8 0.0004
521 HAIR TEXTURE ABNORMAL 5 0.0004
522 COMPRESSION FRACTURE 2 0.0004
523 OVERWEIGHT 2 0.0004
524 CONSTIPATION 81 0.0004
525 HIP SURGERY 2 0.0004
526 ABDOMINAL RIGIDITY 1 0.0004
527 DECUBITUS ULCER 3 0.0004
528 PULMONARY THROMBOSIS 4 0.0004
529 TREATMENT NONCOMPLIANCE 20 0.0004
530 FAECALOMA 2 0.0004
531 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
532 ASTHENOPIA 2 0.0004
533 CHOKING SENSATION 2 0.0004
534 PRESCRIBED OVERDOSE 7 0.0004
535 SYNCOPE 36 0.0004
536 NERVE INJURY 4 0.0004
537 DYSPHONIA 21 0.0004
538 ROAD TRAFFIC ACCIDENT 15 0.0004
539 SNEEZING 8 0.0004
540 MIGRAINE 34 0.0004
541 SEASONAL ALLERGY 5 0.0004
542 PRODUCT AVAILABILITY ISSUE 8 0.0004
543 OFF LABEL USE 307 0.0004
544 INTERNAL HAEMORRHAGE 4 0.0003
545 NEUROLOGICAL SYMPTOM 2 0.0003
546 WEIGHT INCREASED 78 0.0003
547 NEOPLASM 4 0.0003
548 BLOOD MAGNESIUM DECREASED 3 0.0003
549 MUSCLE STRAIN 3 0.0003
550 HYSTERECTOMY 3 0.0003
551 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
552 METABOLIC DISORDER 2 0.0003
553 SINUS HEADACHE 2 0.0003
554 CEREBROVASCULAR ACCIDENT 57 0.0003
555 CARDIAC PACEMAKER INSERTION 2 0.0003
556 ODYNOPHAGIA 2 0.0003
557 FEAR 9 0.0003
558 MOBILITY DECREASED 24 0.0003
559 ABDOMINAL DISCOMFORT 56 0.0003
560 KNEE ARTHROPLASTY 7 0.0003
561 ASTHENIA 125 0.0003
562 MOUTH ULCERATION 7 0.0003
563 TOOTHACHE 6 0.0003
564 LIMB INJURY 9 0.0003
565 HEPATITIS C 4 0.0003
566 MUSCLE SPASTICITY 4 0.0003
567 MENISCUS INJURY 2 0.0003
568 UROSEPSIS 3 0.0003
569 TENDON RUPTURE 4 0.0003
570 PRE-EXISTING CONDITION IMPROVED 2 0.0003
571 PNEUMONIA ASPIRATION 8 0.0003
572 INTESTINAL OBSTRUCTION 12 0.0003
573 FOOT FRACTURE 6 0.0003
574 LIVER DISORDER 14 0.0003
575 OBESITY 5 0.0003
576 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
577 HEART RATE DECREASED 11 0.0003
578 HIATUS HERNIA 4 0.0003
579 INTENTIONAL PRODUCT USE ISSUE 27 0.0003
580 BACK DISORDER 5 0.0003
581 SURGERY 18 0.0003
582 PRODUCT DOSE OMISSION 20 0.0003
583 NECK PAIN 17 0.0003
584 SPINAL FRACTURE 6 0.0003
585 ANXIETY DISORDER 1 0.0003
586 BLOOD POTASSIUM DECREASED 9 0.0003
587 QUALITY OF LIFE DECREASED 4 0.0003
588 ARRHYTHMIA 14 0.0003
589 ABNORMAL LOSS OF WEIGHT 2 0.0003
590 DECREASED APPETITE 68 0.0003
591 CARDIAC DISORDER 27 0.0003
592 BLOOD PRESSURE INCREASED 44 0.0003
593 DEFAECATION URGENCY 2 0.0003
594 SCRATCH 3 0.0003
595 CONTUSION 27 0.0003
596 DIARRHOEA 181 0.0003
597 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
598 DECREASED ACTIVITY 3 0.0003
599 MUSCLE SPASMS 51 0.0003
600 PARAESTHESIA ORAL 4 0.0003
601 PANIC REACTION 2 0.0003
602 FAECES SOFT 2 0.0003
603 EYE DISORDER 9 0.0003
604 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 15 0.0003
605 ALCOHOL USE 1 0.0003
606 DIPLOPIA 7 0.0003
607 VISION BLURRED 37 0.0003
608 HEPATIC STEATOSIS 5 0.0003
609 JOINT STIFFNESS 7 0.0003
610 GENERAL SYMPTOM 2 0.0003
611 EYE INFECTION 3 0.0003
612 REBOUND EFFECT 3 0.0003
613 FRACTURE 5 0.0003
614 HEPATIC ENZYME INCREASED 18 0.0003
615 ECONOMIC PROBLEM 4 0.0003
616 POLLAKIURIA 11 0.0003
617 DEHYDRATION 35 0.0003
618 DISCOMFORT 16 0.0003
619 EPILEPSY 8 0.0003
620 TINNITUS 12 0.0003
621 EAR PAIN 5 0.0003
622 GASTROINTESTINAL DISORDER 23 0.0003
623 SPINAL PAIN 3 0.0003
624 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
625 KIDNEY INFECTION 5 0.0003
626 CYANOSIS 4 0.0003
627 WEIGHT DECREASED 71 0.0003
628 EPISTAXIS 19 0.0003
629 CHEST PAIN 47 0.0003
630 PNEUMOTHORAX 4 0.0003
631 BLOOD ALBUMIN DECREASED 2 0.0003
632 COMPLETED SUICIDE 21 0.0003
633 MYOCLONUS 3 0.0003
634 CEREBRAL HAEMORRHAGE 9 0.0003
635 UPPER LIMB FRACTURE 5 0.0003
636 WRIST FRACTURE 3 0.0003
637 BLOOD DISORDER 2 0.0002
638 ARTERIOSPASM CORONARY 1 0.0002
639 LOCALISED INFECTION 6 0.0002
640 RHINITIS 2 0.0002
641 MYASTHENIA GRAVIS 2 0.0002
642 NOCTURIA 3 0.0002
643 MUSCLE DISORDER 2 0.0002
644 FIBROMYALGIA 6 0.0002
645 PRESYNCOPE 6 0.0002
646 COUGH 69 0.0002
647 BRADYCARDIA 13 0.0002
648 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
649 HICCUPS 2 0.0002
650 MULTIPLE FRACTURES 4 0.0002
651 HAIR DISORDER 2 0.0002
652 EXTRAPYRAMIDAL DISORDER 6 0.0002
653 TOOTH EXTRACTION 3 0.0002
654 LIP SWELLING 8 0.0002
655 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
656 TYPE 2 DIABETES MELLITUS 8 0.0002
657 AORTIC VALVE INCOMPETENCE 1 0.0002
658 DYSPNOEA 133 0.0002
659 VISUAL IMPAIRMENT 29 0.0002
660 INFLUENZA 26 0.0002
661 ABNORMAL SENSATION IN EYE 1 0.0002
662 CARDIAC MURMUR 2 0.0002
663 DELIRIUM 8 0.0002
664 ORTHOSTATIC HYPOTENSION 4 0.0002
665 DEAFNESS 6 0.0002
666 URINE OUTPUT DECREASED 2 0.0002
667 TOOTH INFECTION 3 0.0002
668 PULMONARY CONGESTION 3 0.0002
669 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
670 PRODUCT COMMUNICATION ISSUE 2 0.0002
671 PURPURA 2 0.0002
672 FEMUR FRACTURE 7 0.0002
673 BLOOD PRESSURE DECREASED 15 0.0002
674 EAR INFECTION 6 0.0002
675 RESPIRATORY RATE INCREASED 2 0.0002
676 CHEST DISCOMFORT 23 0.0002
677 SEPSIS 25 0.0002
678 FACIAL PAIN 2 0.0002
679 GOUT 4 0.0002
680 HEAVY MENSTRUAL BLEEDING 2 0.0002
681 CHROMATURIA 5 0.0002
682 NAUSEA 175 0.0002
683 HYPOAESTHESIA 33 0.0002
684 DISEASE PROGRESSION 26 0.0002
685 GINGIVAL BLEEDING 3 0.0002
686 BONE DISORDER 4 0.0002
687 VOMITING 103 0.0002
688 MALAISE 96 0.0002
689 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
690 HYPERTENSION 46 0.0002
691 NASOPHARYNGITIS 40 0.0002
692 BRONCHITIS 16 0.0002
693 OROPHARYNGEAL PAIN 20 0.0002
694 ORAL DISCOMFORT 3 0.0002
695 FEELING COLD 6 0.0002
696 APHONIA 3 0.0002
697 PERIPHERAL SWELLING 33 0.0002
698 CHILLS 25 0.0002
699 ARTERIOSCLEROSIS 2 0.0002
700 FEELING HOT 13 0.0002
701 DIALYSIS 3 0.0002
702 SPUTUM DISCOLOURED 2 0.0002
703 HEADACHE 132 0.0002
704 SEROTONIN SYNDROME 4 0.0002
705 AFFECT LABILITY 2 0.0002
706 HERNIA 4 0.0002
707 ERUCTATION 4 0.0002
708 ATRIAL FIBRILLATION 20 0.0002
709 SWELLING 19 0.0002
710 TACHYCARDIA 18 0.0002
711 BACK PAIN 47 0.0002
712 BLADDER DISORDER 2 0.0002
713 ANEURYSM 1 0.0002
714 HYPOTONIA 2 0.0002
715 DRY EYE 10 0.0002
716 STOMATITIS 12 0.0002
717 AMMONIA INCREASED 1 0.0002
718 OXYGEN SATURATION DECREASED 11 0.0002
719 PHARYNGEAL OEDEMA 3 0.0002
720 PNEUMONIA 63 0.0002
721 MUSCULOSKELETAL CHEST PAIN 3 0.0002
722 THERAPY PARTIAL RESPONDER 3 0.0002
723 NERVOUS SYSTEM DISORDER 6 0.0002
724 WEIGHT FLUCTUATION 2 0.0002
725 TRANSFUSION 2 0.0002
726 PRODUCTIVE COUGH 9 0.0002
727 CYSTITIS 6 0.0002
728 BODY HEIGHT DECREASED 2 0.0002
729 SENSORY DISTURBANCE 3 0.0002
730 HEREDITARY ANGIOEDEMA 2 0.0002
731 GASTROOESOPHAGEAL REFLUX DISEASE 15 0.0002
732 LIVER FUNCTION TEST INCREASED 4 0.0002
733 SKIN LACERATION 2 0.0002
734 STAPHYLOCOCCAL INFECTION 6 0.0002
735 PHOTOSENSITIVITY REACTION 3 0.0002
736 DENTAL CARIES 2 0.0002
737 PAIN 111 0.0002
738 FOOT DEFORMITY 2 0.0002
739 ASTHMA 20 0.0002
740 MITRAL VALVE INCOMPETENCE 2 0.0002
741 DERMATITIS CONTACT 2 0.0002
742 MICTURITION URGENCY 2 0.0002
743 CHOLECYSTECTOMY 2 0.0002
744 THROMBOSIS 14 0.0002
745 ELECTROLYTE IMBALANCE 2 0.0002
746 COLD SWEAT 3 0.0002
747 OSTEOPOROSIS 7 0.0002
748 ABDOMINAL PAIN UPPER 35 0.0002
749 COVID-19 PNEUMONIA 2 0.0002
750 NEUROPATHY PERIPHERAL 16 0.0002
751 MACULAR DEGENERATION 2 0.0002
752 ACCIDENT 2 0.0002
753 RESPIRATORY DISORDER 5 0.0002
754 BLOOD GLUCOSE DECREASED 8 0.0002
755 GASTROENTERITIS VIRAL 3 0.0002
756 COVID-19 29 0.0002
757 ARTHRITIS 13 0.0002
758 DRUG EFFECT INCOMPLETE 6 0.0002
759 PELVIC PAIN 3 0.0002
760 GENERAL PHYSICAL HEALTH DETERIORATION 19 0.0002
761 LUNG DISORDER 8 0.0002
762 HYPERSENSITIVITY 30 0.0002
763 EYE SWELLING 6 0.0002
764 PHARYNGITIS 2 0.0002
765 CYST 2 0.0002
766 HAIR COLOUR CHANGES 2 0.0002
767 HYPOTENSION 32 0.0002
768 PHOTOPHOBIA 3 0.0002
769 POISONING 2 0.0002
770 PARAESTHESIA 25 0.0002
771 PRURITUS 61 0.0002
772 MUSCLE ATROPHY 2 0.0002
773 MUSCULOSKELETAL DISORDER 3 0.0002
774 CARDIOVASCULAR DISORDER 4 0.0002
775 HYPOPHAGIA 4 0.0002
776 MYDRIASIS 2 0.0002
777 NIGHT SWEATS 5 0.0002
778 INJECTION SITE INDURATION 2 0.0002
779 TOXICITY TO VARIOUS AGENTS 26 0.0002
780 SWELLING FACE 10 0.0002
781 NEPHROLITHIASIS 7 0.0002
782 HAND DEFORMITY 2 0.0002
783 CHOLELITHIASIS 5 0.0002
784 SKIN DISCOLOURATION 7 0.0002
785 ADVERSE REACTION 2 0.0002
786 RENAL DISORDER 7 0.0002
787 BLOOD CHOLESTEROL INCREASED 7 0.0002
788 PAIN IN EXTREMITY 44 0.0001
789 FREQUENT BOWEL MOVEMENTS 4 0.0001
790 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
791 MYALGIA 25 0.0001
792 COMA 7 0.0001
793 PRODUCT PREPARATION ERROR 3 0.0001
794 PERIPHERAL COLDNESS 2 0.0001
795 UNEVALUABLE EVENT 11 0.0001
796 TREATMENT FAILURE 12 0.0001
797 URTICARIA 24 0.0001
798 MASS 2 0.0001
799 CARPAL TUNNEL SYNDROME 2 0.0001
800 BLISTER 8 0.0001
801 HYPONATRAEMIA 8 0.0001
802 EYE PAIN 8 0.0001
803 SUBDURAL HAEMATOMA 2 0.0001
804 ANGINA PECTORIS 4 0.0001
805 FLUID RETENTION 7 0.0001
806 GASTROENTERITIS 2 0.0001
807 SINUSITIS 14 0.0001
808 COLON CANCER 2 0.0001
809 HEPATIC FUNCTION ABNORMAL 5 0.0001
810 THROAT IRRITATION 6 0.0001
811 LACRIMATION INCREASED 4 0.0001
812 AORTIC ANEURYSM 1 0.0001
813 HIP ARTHROPLASTY 2 0.0001
814 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
815 DEVICE RELATED INFECTION 2 0.0001
816 THYROID DISORDER 2 0.0001
817 ATRIOVENTRICULAR BLOCK 1 0.0001
818 APHTHOUS ULCER 1 0.0001
819 APNOEA 1 0.0001
820 MULTIPLE SCLEROSIS 6 0.0001
821 HYPOTHYROIDISM 4 0.0001
822 BLOOD PRESSURE FLUCTUATION 3 0.0001
823 FLATULENCE 7 0.0001
824 NEURALGIA 3 0.0001
825 BLOOD CREATININE INCREASED 8 0.0001
826 ASPHYXIA 1 0.0001
827 ENCEPHALOPATHY 3 0.0001
828 IMPAIRED HEALING 4 0.0001
829 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
830 DRUG LEVEL INCREASED 2 0.0001
831 AGEUSIA 3 0.0001
832 COAGULOPATHY 2 0.0001
833 BLOOD UREA INCREASED 2 0.0001
834 HOT FLUSH 9 0.0001
835 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
836 FACE OEDEMA 2 0.0001
837 HEMIPARESIS 2 0.0001
838 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
839 CATARACT 7 0.0001
840 INFECTION 17 0.0001
841 RASH 51 0.0001
842 ERECTILE DYSFUNCTION 3 0.0001
843 SCAR 2 0.0001
844 RESPIRATORY TRACT INFECTION 3 0.0001
845 RASH MACULAR 4 0.0001
846 DEVICE USE ISSUE 2 0.0001
847 GASTRITIS 3 0.0001
848 CARDIAC FAILURE CONGESTIVE 9 0.0001
849 GALLBLADDER DISORDER 2 0.0001
850 BLOOD BILIRUBIN INCREASED 3 0.0001
851 RASH PRURITIC 6 0.0001
852 CARDIAC ARREST 9 0.0001
853 BLOOD GLUCOSE ABNORMAL 2 0.0001
854 PROCEDURAL PAIN 3 0.0001
855 WOUND 3 0.0001
856 BACTERIAL INFECTION 2 0.0001
857 RENAL IMPAIRMENT 9 0.0001
858 HEPATIC CIRRHOSIS 2 0.0001
859 BLOOD URINE PRESENT 2 0.0001
860 NEOPLASM MALIGNANT 7 0.0001
861 RASH ERYTHEMATOUS 5 0.0001
862 PRODUCT SUBSTITUTION ISSUE 6 0.0001
863 DRUG PRESCRIBING ERROR 2 0.0001
864 GLAUCOMA 2 0.0001
865 HAEMORRHOIDS 2 0.0001
866 ORAL HERPES 2 0.0001
867 SKIN FISSURES 2 0.0001
868 OVERDOSE 22 0.0001
869 LABORATORY TEST ABNORMAL 3 0.0001
870 PYREXIA 35 0.0001
871 JOINT SWELLING 12 0.0001
872 CELLULITIS 5 0.0001
873 EXTRA DOSE ADMINISTERED 4 0.0001
874 ARTHRALGIA 41 0.0001
875 MYOCARDIAL INFARCTION 17 0.0001
876 LUNG NEOPLASM MALIGNANT 4 0.0001
877 TOOTH LOSS 2 0.0001
878 RHABDOMYOLYSIS 4 0.0001
879 PANCREATITIS 5 0.0001
880 IRRITABLE BOWEL SYNDROME 2 0.0001
881 SKIN CANCER 2 0.0001
882 FAECES DISCOLOURED 2 0.0001
883 CHRONIC KIDNEY DISEASE 7 0.0001
884 ALOPECIA 18 0.0001
885 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
886 INTENTIONAL PRODUCT MISUSE 8 0.0001
887 ANAPHYLACTIC REACTION 5 0.0001
888 EYE PRURITUS 3 0.0001
889 RASH PAPULAR 2 0.0001
890 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
891 BREAST CANCER 8 0.0001
892 INJURY 6 0.0001
893 BLOOD GLUCOSE INCREASED 16 0.0001
894 WHEEZING 5 0.0001
895 OCULAR HYPERAEMIA 4 0.0001
896 PULMONARY EMBOLISM 8 0.0001
897 RENAL FAILURE 11 0.0001
898 EMOTIONAL DISTRESS 10 0.0001
899 HYPOGLYCAEMIA 4 0.0001
900 ADRENAL INSUFFICIENCY 1 0.0001
901 ACCIDENTAL OVERDOSE 3 0.0001
902 DYSURIA 3 0.0001
903 DYSPEPSIA 8 0.0001
904 PRODUCT COMPLAINT 2 0.0001
905 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
906 SKIN ULCER 2 0.0001
907 ECZEMA 4 0.0001
908 ANHEDONIA 2 0.0001
909 PSORIATIC ARTHROPATHY 3 0.0001
910 PALLOR 2 0.0001
911 ABDOMINAL PAIN 17 0.0001
912 SKIN LESION 2 0.0001
913 DIVERTICULITIS 2 0.0001
914 OSTEOARTHRITIS 3 0.0001
915 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
916 ANOSMIA 1 0.0001
917 FLUSHING 7 0.0001
918 ERYTHEMA 14 0.0001
919 ACUTE MYOCARDIAL INFARCTION 2 0.0001
920 DYSGEUSIA 5 0.0001
921 HYPOKALAEMIA 3 0.0001
922 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
923 BASAL CELL CARCINOMA 1 0.0001
924 DISEASE RECURRENCE 3 0.0001
925 INTENTIONAL OVERDOSE 4 0.0001
926 VISUAL ACUITY REDUCED 2 0.0001
927 EXPIRED PRODUCT ADMINISTERED 2 0.0001
928 VIRAL INFECTION 2 0.0001
929 GASTRIC DISORDER 2 0.0001
930 ABDOMINAL DISTENSION 6 0.0001
931 OEDEMA PERIPHERAL 7 0.0001
932 HAEMORRHAGE 6 0.0001
933 AMENORRHOEA 1 0.0001
934 DERMATITIS ATOPIC 3 0.0001
935 LYMPHADENOPATHY 2 0.0001
936 HAEMATOCHEZIA 3 0.0001
937 INJECTION SITE MASS 2 0.0001
938 DYSPNOEA EXERTIONAL 2 0.0001
939 COLITIS 2 0.0001
940 HERPES ZOSTER 3 0.0001
941 PLASMA CELL MYELOMA 2 0.0001
942 BONE PAIN 3 0.0001
943 INJECTION SITE BRUISING 4 0.0001
944 NEUTROPHIL COUNT DECREASED 2 0.0000
945 HAEMOGLOBIN DECREASED 5 0.0000
946 INFLUENZA LIKE ILLNESS 4 0.0000
947 RECTAL HAEMORRHAGE 2 0.0000
948 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
949 DRUG WITHDRAWAL SYNDROME 4 0.0000
950 APPLICATION SITE PAIN 1 0.0000
951 ANGIOEDEMA 2 0.0000
952 RHEUMATOID ARTHRITIS 5 0.0000
953 SKIN IRRITATION 2 0.0000
954 DRUG DOSE OMISSION 7 0.0000
955 RENAL CANCER 2 0.0000
956 UNDERDOSE 3 0.0000
957 INJECTION SITE SWELLING 3 0.0000
958 ANAPHYLACTIC SHOCK 1 0.0000
959 MUSCULOSKELETAL PAIN 2 0.0000
960 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
961 DRY SKIN 5 0.0000
962 ARTHROPATHY 2 0.0000
963 SKIN EXFOLIATION 3 0.0000
964 THERAPEUTIC RESPONSE DECREASED 2 0.0000
965 ILL-DEFINED DISORDER 2 0.0000
966 PLEURAL EFFUSION 2 0.0000
967 ACUTE KIDNEY INJURY 5 0.0000
968 DEEP VEIN THROMBOSIS 2 0.0000
969 INJECTION SITE PAIN 9 0.0000
970 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
971 BURNING SENSATION 2 0.0000
972 DEVICE MALFUNCTION 2 0.0000
973 PLATELET COUNT DECREASED 3 0.0000
974 ANAEMIA 5 0.0000
975 PROSTATE CANCER 2 0.0000
976 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
977 PRODUCT STORAGE ERROR 2 0.0000
978 PRODUCT QUALITY ISSUE 3 0.0000
979 NO ADVERSE EVENT 4 0.0000
980 NEUTROPENIA 3 0.0000
981 DRUG DEPENDENCE 3 0.0000
982 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
983 INJECTION SITE ERYTHEMA 2 0.0000
984 PSORIASIS 2 0.0000
985 ACNE 1 0.0000